Maze Therapeutics, Inc. (Nasdaq: MAZE) today announced the pricing of its underwritten registered offering of 5,540,000 shares of its common stock at a price of $23.50 per share. In addition, and in ...
THAT MORNING DRIVE. THANK YOU, DEVONTE. HE DOES IT ALL, DOESN’T HE? STOP RIGHT THERE. OKAY. THE MOMENT WE’VE ALL BEEN WAITING FOR, FOR THIS BIG ANNOUNCEMENT, A SPECIAL ONE FROM DEVONTE. YES. AND FIRST ...
Stephanie Nicklow hopes to raise awareness and share her son's health journey with the world Meredith Wilshere is a Society and Culture writer at PEOPLE. Her work has previously appeared on PS, ...
C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results